vs
Samsara Inc.（IOT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Samsara Inc.的1.5倍（$622.0M vs $416.0M），Royalty Pharma plc净利率更高（34.4% vs 1.9%，领先32.6%），Samsara Inc.同比增速更快（29.2% vs 4.8%），过去两年Samsara Inc.的营收复合增速更高（22.7% vs 4.6%）
Samsara Inc.是总部位于美国加利福尼亚州旧金山的物联网企业，专注为实体运营场景提供车联网软件及数据分析服务，客户覆盖北美、欧洲多地。旗下互联运营云平台服务交通、建筑、能源、公用事业、公共部门、零售等领域，助力提升运营的安全性与效率。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
IOT vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.5倍
$416.0M
营收增速更快
IOT
高出24.4%
4.8%
净利率更高
RPRX
高出32.6%
1.9%
两年增速更快
IOT
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $416.0M | $622.0M |
| 净利润 | $7.8M | $214.2M |
| 毛利率 | 76.7% | — |
| 营业利润率 | -0.4% | 62.4% |
| 净利率 | 1.9% | 34.4% |
| 营收同比 | 29.2% | 4.8% |
| 净利润同比 | 120.5% | 2.9% |
| 每股收益（稀释后） | $0.01 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IOTRPRX
| Q4 25 | $416.0M | $622.0M | ||
| Q3 25 | $391.5M | $609.3M | ||
| Q2 25 | $366.9M | $578.7M | ||
| Q1 25 | $346.3M | $568.2M | ||
| Q4 24 | $322.0M | $593.6M | ||
| Q3 24 | $300.2M | $564.7M | ||
| Q2 24 | $280.7M | $537.3M | ||
| Q1 24 | $276.3M | $568.0M |
净利润IOTRPRX
| Q4 25 | $7.8M | $214.2M | ||
| Q3 25 | $-16.8M | $288.2M | ||
| Q2 25 | $-22.1M | $30.2M | ||
| Q1 25 | $-11.2M | $238.3M | ||
| Q4 24 | $-37.8M | $208.2M | ||
| Q3 24 | $-49.6M | $544.0M | ||
| Q2 24 | $-56.3M | $102.0M | ||
| Q1 24 | $-113.4M | $4.8M |
毛利率IOTRPRX
| Q4 25 | 76.7% | — | ||
| Q3 25 | 76.9% | — | ||
| Q2 25 | 77.3% | — | ||
| Q1 25 | 76.8% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 75.6% | — | ||
| Q1 24 | 75.0% | — |
营业利润率IOTRPRX
| Q4 25 | -0.4% | 62.4% | ||
| Q3 25 | -6.8% | 70.1% | ||
| Q2 25 | -9.1% | 36.3% | ||
| Q1 25 | -5.3% | 94.0% | ||
| Q4 24 | -14.7% | 60.9% | ||
| Q3 24 | -19.4% | — | ||
| Q2 24 | -23.5% | 50.2% | ||
| Q1 24 | -44.5% | -13.0% |
净利率IOTRPRX
| Q4 25 | 1.9% | 34.4% | ||
| Q3 25 | -4.3% | 47.3% | ||
| Q2 25 | -6.0% | 5.2% | ||
| Q1 25 | -3.2% | 41.9% | ||
| Q4 24 | -11.7% | 35.1% | ||
| Q3 24 | -16.5% | 96.3% | ||
| Q2 24 | -20.1% | 19.0% | ||
| Q1 24 | -41.0% | 0.8% |
每股收益（稀释后）IOTRPRX
| Q4 25 | $0.01 | $0.49 | ||
| Q3 25 | $-0.03 | $0.67 | ||
| Q2 25 | $-0.04 | $0.07 | ||
| Q1 25 | $-0.02 | $0.55 | ||
| Q4 24 | $-0.07 | $0.46 | ||
| Q3 24 | $-0.09 | $1.21 | ||
| Q2 24 | $-0.10 | $0.23 | ||
| Q1 24 | $-0.22 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $275.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.3B | $9.7B |
| 总资产 | $2.3B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资IOTRPRX
| Q4 25 | $275.1M | $618.7M | ||
| Q3 25 | $258.5M | $938.9M | ||
| Q2 25 | $259.0M | $631.9M | ||
| Q1 25 | $227.6M | $1.1B | ||
| Q4 24 | $160.3M | $929.0M | ||
| Q3 24 | $159.3M | $950.1M | ||
| Q2 24 | $162.5M | $1.8B | ||
| Q1 24 | $135.5M | $843.0M |
总债务IOTRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益IOTRPRX
| Q4 25 | $1.3B | $9.7B | ||
| Q3 25 | $1.2B | $9.6B | ||
| Q2 25 | $1.1B | $9.5B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $999.1M | $10.3B | ||
| Q3 24 | $964.7M | $10.3B | ||
| Q2 24 | $923.9M | $9.8B | ||
| Q1 24 | $915.1M | $9.9B |
总资产IOTRPRX
| Q4 25 | $2.3B | $19.6B | ||
| Q3 25 | $2.2B | $19.3B | ||
| Q2 25 | $2.1B | $18.3B | ||
| Q1 25 | $2.0B | $17.6B | ||
| Q4 24 | $1.9B | $18.2B | ||
| Q3 24 | $1.8B | $18.0B | ||
| Q2 24 | $1.7B | $17.7B | ||
| Q1 24 | $1.7B | $16.1B |
负债/权益比IOTRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | — |
| 自由现金流率自由现金流/营收 | 13.4% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | 8.20× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $194.2M | — |
8季度趋势，按日历期对齐
经营现金流IOTRPRX
| Q4 25 | $63.7M | $827.1M | ||
| Q3 25 | $50.2M | $702.6M | ||
| Q2 25 | $52.6M | $364.0M | ||
| Q1 25 | $53.9M | $596.1M | ||
| Q4 24 | $36.0M | $742.5M | ||
| Q3 24 | $18.1M | $703.6M | ||
| Q2 24 | $23.7M | $658.2M | ||
| Q1 24 | $-41.9M | $664.6M |
自由现金流IOTRPRX
| Q4 25 | $55.8M | — | ||
| Q3 25 | $44.2M | — | ||
| Q2 25 | $45.7M | — | ||
| Q1 25 | $48.5M | — | ||
| Q4 24 | $31.2M | — | ||
| Q3 24 | $13.1M | — | ||
| Q2 24 | $18.6M | — | ||
| Q1 24 | $-44.0M | — |
自由现金流率IOTRPRX
| Q4 25 | 13.4% | — | ||
| Q3 25 | 11.3% | — | ||
| Q2 25 | 12.5% | — | ||
| Q1 25 | 14.0% | — | ||
| Q4 24 | 9.7% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 6.6% | — | ||
| Q1 24 | -15.9% | — |
资本支出强度IOTRPRX
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 0.8% | — |
现金转化率IOTRPRX
| Q4 25 | 8.20× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IOT
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
